
Agios Pharmaceuticals Inc
AGIONASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$29.09
Day High
$30.28
Day Low
$28.50
Prev. Close
$30.42
VolumeShares traded today.
1.23M
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$1.75B
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-4.06
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$46.00
52W LowLowest price over the past 52 weeks.
$22.24
50D MAAverage closing price over the last 50 trading days.
$29.53
200D MAAverage closing price over the last 200 trading days.
$32.31
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+2.1%1M
+4.8%6M
+3.4%YTD
+8.2%1Y
-8.4%About
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
www.agios.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade AGIO
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.